Clinical trial
Combining Varenicline and Guanfacine for Smoking Cessation
NCT04198116 is registered in ClinicalTrials.gov with Yale University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Combining Varenicline and Guanfacine for Smoking Cessation
- Lead sponsor
- Yale University
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 1, 2020
- Completion date
- April 30, 2025
- Enrollment
- 167 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
smoking cessation